Immunome Stock Price History

IMNM Stock  USD 9.99  0.13  1.32%   
If you're considering investing in Immunome Stock, it is important to understand the factors that can impact its price. As of today, the current price of Immunome stands at 9.99, as last reported on the 21st of January, with the highest price reaching 10.39 and the lowest price hitting 9.69 during the day. Immunome holds Efficiency (Sharpe) Ratio of -0.0245, which attests that the entity had a -0.0245 % return per unit of risk over the last 3 months. Immunome exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out Immunome's Market Risk Adjusted Performance of (0.15), risk adjusted performance of (0.01), and Standard Deviation of 5.0 to validate the risk estimate we provide.
  
Immunome Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = -0.0245

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsIMNM

Estimated Market Risk

 5.08
  actual daily
45
55% of assets are more volatile

Expected Return

 -0.12
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.02
  actual daily
0
Most of other assets perform better
Based on monthly moving average Immunome is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Immunome by adding Immunome to a well-diversified portfolio.

Immunome Stock Price History Chart

There are several ways to analyze Immunome Stock price data. The simplest method is using a basic Immunome candlestick price chart, which shows Immunome price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest PriceDecember 9, 202414.53
Lowest PriceNovember 20, 20249.33

Immunome January 21, 2025 Stock Price Synopsis

Various analyses of Immunome's daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Immunome Stock. It can be used to describe the percentage change in the price of Immunome from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Immunome Stock.
Immunome Price Action Indicator 0.02 
Immunome Price Daily Balance Of Power 0.19 
Immunome Price Rate Of Daily Change 1.01 

Immunome January 21, 2025 Stock Price Analysis

When benchmark price declines in a down market, there may be an uptick in Immunome Stock price where buyers come in believing the asset is cheap or selling overdone. The opposite is true when the market is bullish. You can use Immunome intraday prices and daily technical indicators to check the level of noise trading in Immunome Stock and then apply it to test your longer-term investment strategies against Immunome.

Immunome Stock Price History Data

The price series of Immunome for the period between Wed, Oct 23, 2024 and Tue, Jan 21, 2025 has a statistical range of 5.2 with a coefficient of variation of 12.15. Under current investment horizon, the daily prices are spread out with arithmetic mean of 11.63. The median price for the last 90 days is 11.53.
OpenHighLowCloseVolume
01/21/2025
 10.02  10.39  9.69  9.99 
01/17/2025 10.02  10.39  9.69  9.99  900,330 
01/16/2025 10.63  11.06  9.60  9.86  1,313,542 
01/15/2025 9.81  10.15  9.50  10.11  670,321 
01/14/2025 10.12  10.13  9.24  9.38  517,590 
01/13/2025 10.35  10.49  9.36  10.04  1,036,384 
01/10/2025 10.37  10.66  10.27  10.60  865,085 
01/08/2025 10.72  10.85  10.35  10.66  334,889 
01/07/2025 11.40  11.60  10.71  10.76  371,654 
01/06/2025 11.46  11.56  11.03  11.20  568,465 
01/03/2025 10.61  11.36  10.61  11.27  705,199 
01/02/2025 10.72  11.16  10.47  10.53  579,297 
12/31/2024 10.43  10.74  10.20  10.62  1,036,301 
12/30/2024 10.42  10.57  10.11  10.28  464,305 
12/27/2024 11.00  11.16  10.37  10.54  2,457,083 
12/26/2024 11.00  11.28  10.84  11.10  377,611 
12/24/2024 10.98  11.08  10.67  11.02  594,254 
12/23/2024 10.97  11.08  10.75  10.97  1,281,110 
12/20/2024 10.94  11.50  10.82  10.97  1,453,565 
12/19/2024 11.26  11.44  10.86  11.08  1,029,555 
12/18/2024 12.01  12.14  10.76  11.11  1,076,071 
12/17/2024 12.40  12.54  11.70  12.02  894,575 
12/16/2024 12.55  12.85  12.23  12.44  548,487 
12/13/2024 13.00  13.13  12.34  12.58  595,219 
12/12/2024 13.47  14.09  13.00  13.07  535,087 
12/11/2024 13.99  14.10  12.99  14.04  671,537 
12/10/2024 14.42  14.42  13.34  13.90  699,885 
12/09/2024 13.90  15.13  13.90  14.53  796,219 
12/06/2024 12.83  13.84  12.55  13.73  462,461 
12/05/2024 13.47  13.63  12.67  12.70  661,748 
12/04/2024 13.65  14.09  12.96  13.54  896,480 
12/03/2024 14.00  14.17  13.27  13.54  679,021 
12/02/2024 13.93  14.47  13.64  14.08  972,423 
11/29/2024 13.44  13.66  13.08  13.55  438,919 
11/27/2024 11.68  13.53  11.62  13.47  1,383,648 
11/26/2024 11.15  11.81  10.82  11.53  1,014,855 
11/25/2024 11.10  11.31  10.67  11.15  2,247,455 
11/22/2024 9.46  10.03  9.32  9.82  1,176,158 
11/21/2024 9.43  9.71  9.05  9.42  662,955 
11/20/2024 9.29  9.36  8.97  9.33  700,392 
11/19/2024 9.28  9.53  9.19  9.39  705,339 
11/18/2024 10.20  10.20  9.41  9.44  1,877,386 
11/15/2024 11.19  11.19  9.64  9.90  3,166,549 
11/14/2024 11.57  11.66  10.70  11.14  1,350,565 
11/13/2024 12.74  12.77  11.55  11.59  613,682 
11/12/2024 12.93  13.09  12.40  12.49  519,822 
11/11/2024 13.22  13.52  12.70  13.26  416,500 
11/08/2024 13.26  13.47  12.71  12.98  547,758 
11/07/2024 13.09  13.63  12.46  12.54  632,999 
11/06/2024 13.45  13.66  13.02  13.10  571,382 
11/05/2024 12.78  13.00  12.50  12.97  414,797 
11/04/2024 11.52  12.86  11.40  12.81  672,948 
11/01/2024 11.81  11.92  11.48  11.59  632,575 
10/31/2024 12.07  12.08  11.43  11.47  507,607 
10/30/2024 12.06  12.42  11.90  12.20  261,637 
10/29/2024 12.47  12.47  11.93  12.20  381,013 
10/28/2024 12.34  12.72  12.17  12.43  289,613 
10/25/2024 12.10  12.65  11.91  12.11  501,562 
10/24/2024 11.73  12.06  11.64  12.01  352,171 
10/23/2024 11.64  11.91  11.33  11.60  415,021 
10/22/2024 11.82  11.91  11.36  11.71  789,125 

About Immunome Stock history

Immunome investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Immunome is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Immunome will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Immunome stock prices may prove useful in developing a viable investing in Immunome
Immunome, Inc., a biopharmaceutical company, discovers and develops antibody therapeutics for oncology and infectious disease. The company was incorporated in 2006 and is headquartered in Exton, Pennsylvania. Immunome operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs people.

Immunome Stock Technical Analysis

Immunome technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Immunome technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Immunome trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Did you try this?

Run Insider Screener Now

   

Insider Screener

Find insiders across different sectors to evaluate their impact on performance
All  Next Launch Module

Immunome Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Immunome's price direction in advance. Along with the technical and fundamental analysis of Immunome Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Immunome to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
When determining whether Immunome is a strong investment it is important to analyze Immunome's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Immunome's future performance. For an informed investment choice regarding Immunome Stock, refer to the following important reports:
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Immunome. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
To learn how to invest in Immunome Stock, please use our How to Invest in Immunome guide.
You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Immunome. If investors know Immunome will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Immunome listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Immunome is measured differently than its book value, which is the value of Immunome that is recorded on the company's balance sheet. Investors also form their own opinion of Immunome's value that differs from its market value or its book value, called intrinsic value, which is Immunome's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Immunome's market value can be influenced by many factors that don't directly affect Immunome's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Immunome's value and its price as these two are different measures arrived at by different means. Investors typically determine if Immunome is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Immunome's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.